Stay updated on Dupilumab in Pediatric Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Pediatric Asthma Clinical Trial page.

Latest updates to the Dupilumab in Pediatric Asthma Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 label on the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-status notice and Revision: v3.4.1 text.SummaryDifference0.2%

- Check40 days agoChange DetectedA government funding lapse notice was added at the top of the page, stating possible processing delays and directing users to opm.gov for updates. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check47 days agoChange DetectedAdded a Show glossary toggle and updated QC/version labels (Last Update Submitted that Met QC Criteria, Revision: v3.4.0). These are minor UI/metadata updates that do not affect core study content or functionality.SummaryDifference0.1%

- Check61 days agoChange DetectedPage revision label updated to v3.3.4; the previous revision label v3.3.3 was removed.SummaryDifference0.0%

- Check83 days agoChange DetectedIntroduces a consolidated Locations section listing study sites by state (Alabama, Arizona, California, Kentucky, Michigan, Missouri, Nebraska, New York, North Carolina, Ohio, Oklahoma, Texas, Wisconsin). Removes the previous per-state location entries and the HHS Vulnerability Disclosure link, and updates the revision tag to v3.3.3.SummaryDifference0.7%

Stay in the know with updates to Dupilumab in Pediatric Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Pediatric Asthma Clinical Trial page.